Tamara A. Ranalli - May 27, 2022 Form 4 Insider Report for QUIDEL CORP /DE/ (QDEL)

Role
SVP, Molecular Bus. Unit
Signature
/s/ Phillip S. Askim, attorney-in-fact for Tamara A. Ranalli
Stock symbol
QDEL
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 04:29 PM
Previous filing
Feb 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Disposed to Issuer -15.5K -100% 0 May 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -3.19K -100% $0.00* 0 May 27, 2022 Common Stock 3.19K $22.21 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -6.36K -100% $0.00* 0 May 27, 2022 Common Stock 6.36K $27.57 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -3.91K -100% $0.00* 0 May 27, 2022 Common Stock 3.91K $23.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1.95K -100% $0.00* 0 May 27, 2022 Common Stock 1.95K $15.40 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1.35K -100% $0.00* 0 May 27, 2022 Common Stock 1.35K $21.08 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -3.46K -100% $0.00* 0 May 27, 2022 Common Stock 3.46K $46.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -3.02K -100% $0.00* 0 May 27, 2022 Common Stock 3.02K $59.12 Direct F2, F4
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -2.37K -100% $0.00* 0 May 27, 2022 Common Stock 2.37K $77.16 Direct F2, F5
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1.91K -100% $0.00* 0 May 27, 2022 Common Stock 1.91K $228.21 Direct F2, F6
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1.89K -100% $0.00* 0 May 27, 2022 Common Stock 1.89K $254.00 Direct F2, F7
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -4.96K -100% $0.00* 0 May 27, 2022 Common Stock 4.96K $103.36 Direct F2, F8
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1.51K -100% $0.00* 0 May 27, 2022 Common Stock 1.51K Direct F9, F10, F11
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1.19K -100% $0.00* 0 May 27, 2022 Common Stock 1.19K Direct F9, F10, F12
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -591 -100% $0.00* 0 May 27, 2022 Common Stock 591 Direct F9, F10, F13
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1.42K -100% $0.00* 0 May 27, 2022 Common Stock 1.42K Direct F9, F10, F14
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -4.96K -100% $0.00* 0 May 27, 2022 Common Stock 4.96K Direct F9, F10, F15
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -3.39K -100% $0.00* 0 May 27, 2022 Common Stock 3.39K Direct F9, F10, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Tamara A. Ranalli is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2 Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3 Vested in full.
F4 2,265 shares are vested in full; 755 shares will vest on February 4, 2023.
F5 1,186 shares are vested in full; the remaining 1,186 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F6 476 shares are vested in full; 476 shares will vest on August 24, 2022; the remaining 954 shares will vest in equal installments on August 24, 2023 and August 24, 2024.
F7 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F8 1,239 shares will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025;1,240 shares will vest on January 31, 2026.
F9 Each restricted stock unit represents the right to receive one share of Quidel common stock.
F10 Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F11 1,510 shares will vest on February 4, 2023.
F12 1,186 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F13 591 shares will vest in equal installments on August 24, 2022, August 24, 2023 and August 24, 2024.
F14 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
F15 1,239 shares will vest on each of January 31, 2023 and January 31, 2024; 1,240 shares will vest on each of January 31, 2025 and January 31, 2026.
F16 1,693 shares will vest on January 31, 2024; 846 shares will vest on January 31, 2025; and 847 shares will vest on January 31, 2026.